Stoke Therapeutics, Inc. Capital Expenditures
Stoke Therapeutics, Inc. (STOK) reported Capital Expenditures of $2.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-03
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.98M, a 1183.12% increase year-over-year.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $353.00K, a 132.24% increase year-over-year.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $232.00K, a 452.38% increase year-over-year.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $132.00K, a 28.16% increase year-over-year.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $670.00K, a 230.05% increase from fiscal 2024.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $203.00K, a 87.44% decline from fiscal 2023.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.62M, a 59.21% decline from fiscal 2022.
- Stoke Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $3.96M, a 230.17% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $2.33M 10-Q · filed 2026-08-03 | $2.56M derived: sum of 3 quarters · filed 2026-08-03 | $2.69M derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $353.00K 10-Q · filed 2026-05-07 | $585.00K derived: sum of 2 quarters · filed 2026-05-07 | $717.00K derived: sum of 3 quarters · filed 2026-05-07 | $871.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $364.00K derived: sum of 2 quarters · filed 2026-03-16 | $518.00K derived: sum of 3 quarters · filed 2026-08-03 | $670.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $132.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $286.00K derived: sum of 2 quarters · filed 2026-08-03 | $438.00K 10-Q · filed 2025-11-04 | $480.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $306.00K 10-Q · filed 2026-08-03 | $348.00K derived: sum of 3 quarters · filed 2026-08-03 | $451.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $152.00K 10-Q · filed 2026-05-07 | $194.00K derived: sum of 2 quarters · filed 2026-05-07 | $297.00K derived: sum of 3 quarters · filed 2026-05-07 | $343.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $145.00K derived: sum of 2 quarters · filed 2026-03-16 | $191.00K derived: sum of 3 quarters · filed 2026-03-16 | $203.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $149.00K derived: sum of 2 quarters · filed 2025-11-04 | $161.00K 10-Q · filed 2025-11-04 | $390.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $46.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $58.00K 10-Q · filed 2025-08-12 | $287.00K derived: sum of 3 quarters · filed 2025-08-12 | $670.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $12.00K 10-Q · filed 2025-05-13 | $241.00K derived: sum of 2 quarters · filed 2025-05-13 | $624.00K derived: sum of 3 quarters · filed 2025-05-13 | $1.46M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $612.00K derived: sum of 2 quarters · filed 2025-03-18 | $1.45M derived: sum of 3 quarters · filed 2025-03-18 | $1.62M 10-K · filed 2025-03-18 |
| 2023-09-30 | $383.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.22M derived: sum of 2 quarters · filed 2024-11-05 | $1.39M 10-Q · filed 2024-11-05 | $1.80M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.00M 10-Q · filed 2024-08-07 | $1.41M derived: sum of 3 quarters · filed 2024-08-07 | $3.44M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $165.00K 10-Q · filed 2024-05-06 | $574.00K derived: sum of 2 quarters · filed 2024-05-06 | $2.60M derived: sum of 3 quarters · filed 2024-05-06 | $3.29M derived: sum of 4 quarters · filed 2024-05-06 |
| 2022-12-31 | $409.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.44M derived: sum of 2 quarters · filed 2024-03-25 | $3.12M derived: sum of 3 quarters · filed 2024-03-25 | $3.96M 10-K · filed 2024-03-25 |
| 2022-09-30 | $2.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $2.71M derived: sum of 2 quarters · filed 2023-11-07 | $3.55M 10-Q · filed 2023-11-07 | $3.76M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $682.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $1.52M 10-Q · filed 2023-08-07 | $1.73M derived: sum of 3 quarters · filed 2023-08-07 | $2.00M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $841.00K 10-Q · filed 2023-05-04 | $1.04M derived: sum of 2 quarters · filed 2023-05-04 | $1.32M derived: sum of 3 quarters · filed 2023-05-04 | $1.84M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $476.00K derived: sum of 2 quarters · filed 2023-03-06 | $996.00K derived: sum of 3 quarters · filed 2023-03-06 | $1.20M 10-K · filed 2023-03-06 |
| 2021-09-30 | $273.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $793.00K derived: sum of 2 quarters · filed 2022-11-14 | $997.00K 10-Q · filed 2022-11-14 | $1.09M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $520.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $724.00K 10-Q · filed 2022-08-08 | $814.00K derived: sum of 3 quarters · filed 2022-08-08 | $1.08M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $204.00K 10-Q · filed 2022-05-10 | $294.00K derived: sum of 2 quarters · filed 2022-05-10 | $563.00K derived: sum of 3 quarters · filed 2022-05-10 | $644.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $359.00K derived: sum of 2 quarters · filed 2022-03-10 | $440.00K derived: sum of 3 quarters · filed 2022-03-10 | $1.05M 10-K · filed 2022-03-10 |
| 2020-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $350.00K derived: sum of 2 quarters · filed 2021-11-08 | $960.00K 10-Q · filed 2021-11-08 | $1.53M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $691.00K 10-Q · filed 2021-08-10 | $1.26M derived: sum of 3 quarters · filed 2021-08-10 | $1.84M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $610.00K 10-Q · filed 2021-05-10 | $1.18M derived: sum of 2 quarters · filed 2021-05-10 | $1.76M derived: sum of 3 quarters · filed 2021-05-10 | $2.15M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $568.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $1.15M derived: sum of 2 quarters · filed 2021-03-09 | $1.54M derived: sum of 3 quarters · filed 2021-03-09 | $1.64M 10-K · filed 2021-03-09 |
| 2019-09-30 | $583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $975.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.07M 10-Q · filed 2020-11-12 | $1.16M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $484.00K 10-Q · filed 2020-08-10 | $577.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.09M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $92.00K 10-Q · filed 2020-05-15 | $185.00K derived: sum of 2 quarters · filed 2020-05-15 | $701.00K derived: sum of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $609.00K derived: sum of 2 quarters · filed 2020-03-23 | $935.00K 10-K · filed 2020-03-23 | |
| 2018-09-30 | $516.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $842.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $326.00K 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |